Profil
Bruce A. Chabner is currently the Clinical Director at Massachusetts General Hospital Cancer Center, Associate Director-Clinical Science at Dana-Farber, and a Professor at Harvard University.
He previously worked as the Director at Kosan Biosciences, Inc., Clinical Research Director-Cancer Center at The General Hospital Corp., Director at Pharma Mar SA, and Advisor at Thomas, McNerney & Partners LLC.
He also served as a Trustee at Nantucket Cottage Hospital.
Chabner earned a doctorate degree from Harvard University.
Postes actifs de Bruce Chabner
| Sociétés | Poste | Début |
|---|---|---|
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/1995 |
The Massachusetts General Hospital
The Massachusetts General Hospital Hospital/Nursing ManagementHealth Services Operates as a cancer care hospital | Directeur Technique/Scientifique/R&D | 01/01/1995 |
Dana-Farber/Harvard Cancer Center
Dana-Farber/Harvard Cancer Center Hospital/Nursing ManagementHealth Services Operates as cancer center | Directeur Technique/Scientifique/R&D | 01/01/1999 |
Anciens postes connus de Bruce Chabner
| Sociétés | Poste | Fin |
|---|---|---|
Kosan Biosciences, Inc.
Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for cancer therapeutics | Directeur/Membre du Conseil | 26/06/2008 |
| PHARMA MAR, S.A. | Directeur/Membre du Conseil | - |
Nantucket Cottage Hospital
Nantucket Cottage Hospital Miscellaneous Commercial ServicesCommercial Services Provides healthcare services | Directeur/Membre du Conseil | - |
The General Hospital Corp.
The General Hospital Corp. Hospital/Nursing ManagementHealth Services Functions as a non profit organization that operates general hospital | Directeur Technique/Scientifique/R&D | - |
Thomas, McNerney & Partners LLC
Thomas, McNerney & Partners LLC Investment ManagersFinance TMT invests in companies located in the United States. The firm targets companies operating in the fields of life sciences and medical technology. It participates in restructuring transactions including spin-outs, roll ups and recapitalizations with an investment size of USD 5 - 40 million. | Private Equity Investor | - |
Formation de Bruce Chabner
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Kosan Biosciences, Inc.
Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for cancer therapeutics | Health Technology |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The General Hospital Corp.
The General Hospital Corp. Hospital/Nursing ManagementHealth Services Functions as a non profit organization that operates general hospital | Health Services |
Pharma Mar SA
Pharma Mar SA Pharmaceuticals: OtherHealth Technology Operates as a biopharmaceutical company | Health Technology |
Thomas, McNerney & Partners LLC
Thomas, McNerney & Partners LLC Investment ManagersFinance TMT invests in companies located in the United States. The firm targets companies operating in the fields of life sciences and medical technology. It participates in restructuring transactions including spin-outs, roll ups and recapitalizations with an investment size of USD 5 - 40 million. | Finance |
The Massachusetts General Hospital
The Massachusetts General Hospital Hospital/Nursing ManagementHealth Services Operates as a cancer care hospital | Health Services |
Dana-Farber/Harvard Cancer Center
Dana-Farber/Harvard Cancer Center Hospital/Nursing ManagementHealth Services Operates as cancer center | Health Services |
Nantucket Cottage Hospital
Nantucket Cottage Hospital Miscellaneous Commercial ServicesCommercial Services Provides healthcare services | Commercial Services |
















